Belgave Pharma And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-12-2024
- Paid Up Capital ₹ 0.10 M
as on 09-12-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Belgave Pharma And Healthcare
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Belgave and Sunil Belgave serve as directors at the Company.
- CIN/LLPIN
U51909PN2016PTC158398
- Company No.
158398
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Sangli, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Belgave Pharma And Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Belgave  | Director | 13-Feb-2016 | Current |
| Sunil Belgave | Director | 13-Feb-2016 | Current |
Financial Performance of Belgave Pharma And Healthcare.
Belgave Pharma And Healthcare Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Belgave Pharma And Healthcare?
In 2017, Belgave Pharma And Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Belgave Education Private LimitedActive 8 years 10 monthsGeeta Belgave and Sunil Belgave are mutual person
Belgave E-Commerce Private LimitedActive 8 years 10 monthsGeeta Belgave and Sunil Belgave are mutual person
Belgave Dealer And Distributorship Private LimitedActive 8 years 10 monthsGeeta Belgave and Sunil Belgave are mutual person
Belgave Food And Agriculture Services Private LimitedActive 8 years 10 monthsGeeta Belgave and Sunil Belgave are mutual person
- Belgave Land Development & Construction Private LimitedActive 8 years 10 months
Geeta Belgave and Sunil Belgave are mutual person
- Belgave It Services Private LimitedActive 8 years 10 months
Geeta Belgave and Sunil Belgave are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Belgave Pharma And Healthcare?
Unlock and access historical data on people associated with Belgave Pharma And Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Belgave Pharma And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Belgave Pharma And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
